| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |